Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology

Herve Rhinn, Liang Qiang, Toru Yamashita, David Rhee, Ari Zolin, William Vanti, Asa Abeliovich

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

α-Synuclein is implicated both in physiological functions at neuronal synaptic terminals as well as in pathological processes in the context of Parkinson's disease. However, the molecular mechanisms for these apparently diverse roles are unclear. Here we show that specific RNA transcript isoforms of α-synuclein with an extended 3′ untranslated region, termed aSynL, appear selectively linked to pathological processes, relative to shorter α-synuclein transcripts. Common variants in the aSynL 3′ untranslated region associated with Parkinson's disease risk promote the accumulation and translation of aSynL transcripts. The presence of intracellular dopamine can further enhance the relative abundance of aSynL transcripts through alternative polyadenylation site selection. We demonstrate that the presence of the extended aSynL transcript 3′ untranslated region impacts accumulation of α-synuclein protein, which appears redirected away from synaptic terminals and towards mitochondria, reminiscent of Parkinson's disease pathology. Taken together, these findings identify a novel mechanism for aSyn regulation in the context of Parkinson's disease-associated genetic and environmental variations.

Original languageEnglish
Article number1084
JournalNature Communications
Volume3
DOIs
Publication statusPublished - 2012
Externally publishedYes

Fingerprint

Synucleins
Parkinson disease
pathology
Pathology
Parkinson Disease
3' Untranslated Regions
Presynaptic Terminals
Pathologic Processes
site selection
RNA Isoforms
Site selection
dopamine
Polyadenylation
Mitochondria
mitochondria
Dopamine
Protein Isoforms
RNA
proteins
Proteins

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Chemistry(all)
  • Physics and Astronomy(all)

Cite this

Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology. / Rhinn, Herve; Qiang, Liang; Yamashita, Toru; Rhee, David; Zolin, Ari; Vanti, William; Abeliovich, Asa.

In: Nature Communications, Vol. 3, 1084, 2012.

Research output: Contribution to journalArticle

Rhinn, Herve ; Qiang, Liang ; Yamashita, Toru ; Rhee, David ; Zolin, Ari ; Vanti, William ; Abeliovich, Asa. / Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology. In: Nature Communications. 2012 ; Vol. 3.
@article{8428339506664e0e858cd9472d39a69c,
title = "Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology",
abstract = "α-Synuclein is implicated both in physiological functions at neuronal synaptic terminals as well as in pathological processes in the context of Parkinson's disease. However, the molecular mechanisms for these apparently diverse roles are unclear. Here we show that specific RNA transcript isoforms of α-synuclein with an extended 3′ untranslated region, termed aSynL, appear selectively linked to pathological processes, relative to shorter α-synuclein transcripts. Common variants in the aSynL 3′ untranslated region associated with Parkinson's disease risk promote the accumulation and translation of aSynL transcripts. The presence of intracellular dopamine can further enhance the relative abundance of aSynL transcripts through alternative polyadenylation site selection. We demonstrate that the presence of the extended aSynL transcript 3′ untranslated region impacts accumulation of α-synuclein protein, which appears redirected away from synaptic terminals and towards mitochondria, reminiscent of Parkinson's disease pathology. Taken together, these findings identify a novel mechanism for aSyn regulation in the context of Parkinson's disease-associated genetic and environmental variations.",
author = "Herve Rhinn and Liang Qiang and Toru Yamashita and David Rhee and Ari Zolin and William Vanti and Asa Abeliovich",
year = "2012",
doi = "10.1038/ncomms2032",
language = "English",
volume = "3",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology

AU - Rhinn, Herve

AU - Qiang, Liang

AU - Yamashita, Toru

AU - Rhee, David

AU - Zolin, Ari

AU - Vanti, William

AU - Abeliovich, Asa

PY - 2012

Y1 - 2012

N2 - α-Synuclein is implicated both in physiological functions at neuronal synaptic terminals as well as in pathological processes in the context of Parkinson's disease. However, the molecular mechanisms for these apparently diverse roles are unclear. Here we show that specific RNA transcript isoforms of α-synuclein with an extended 3′ untranslated region, termed aSynL, appear selectively linked to pathological processes, relative to shorter α-synuclein transcripts. Common variants in the aSynL 3′ untranslated region associated with Parkinson's disease risk promote the accumulation and translation of aSynL transcripts. The presence of intracellular dopamine can further enhance the relative abundance of aSynL transcripts through alternative polyadenylation site selection. We demonstrate that the presence of the extended aSynL transcript 3′ untranslated region impacts accumulation of α-synuclein protein, which appears redirected away from synaptic terminals and towards mitochondria, reminiscent of Parkinson's disease pathology. Taken together, these findings identify a novel mechanism for aSyn regulation in the context of Parkinson's disease-associated genetic and environmental variations.

AB - α-Synuclein is implicated both in physiological functions at neuronal synaptic terminals as well as in pathological processes in the context of Parkinson's disease. However, the molecular mechanisms for these apparently diverse roles are unclear. Here we show that specific RNA transcript isoforms of α-synuclein with an extended 3′ untranslated region, termed aSynL, appear selectively linked to pathological processes, relative to shorter α-synuclein transcripts. Common variants in the aSynL 3′ untranslated region associated with Parkinson's disease risk promote the accumulation and translation of aSynL transcripts. The presence of intracellular dopamine can further enhance the relative abundance of aSynL transcripts through alternative polyadenylation site selection. We demonstrate that the presence of the extended aSynL transcript 3′ untranslated region impacts accumulation of α-synuclein protein, which appears redirected away from synaptic terminals and towards mitochondria, reminiscent of Parkinson's disease pathology. Taken together, these findings identify a novel mechanism for aSyn regulation in the context of Parkinson's disease-associated genetic and environmental variations.

UR - http://www.scopus.com/inward/record.url?scp=84867021118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867021118&partnerID=8YFLogxK

U2 - 10.1038/ncomms2032

DO - 10.1038/ncomms2032

M3 - Article

C2 - 23011138

AN - SCOPUS:84867021118

VL - 3

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 1084

ER -